Join Bedfont® Scientific Limited & Heart of Kent Hospice for their Bluebell Walk 2024, on Sunday, 5th May.

FHS
May 1, 2024
10:22 am

Timber Pharmaceuticals’ candidate for rare skin disorder flunks all endpoints in late-stage trial

Dermatology biotech Timber Pharmaceuticals’ Phase 3 trial investigating its treatment in a rare inherited skin disorder missed all primary and secondary endpoints, the company announced

August 22, 2024

Syros stock craters after lead cancer therapy flops in Phase III trial

Syros noted that SELCT-MDS-1 Phase III trial’s failure to meet its endpoint constituted a default event under its secured loan facility with Oxford Finance. Image

November 13, 2024

Exercise pattern study reveals lower Parkinson’s risk for weekend warriors and regulars alike

A recent study in npj Digital Medicine found that both “weekend warrior” and regular exercise patterns significantly reduce Parkinson’s disease (PD) risk. The findings suggest

May 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.